Liquid Biopsy – Market Insights – United States
Although the COVID-19 pandemic will limit growth in the initial years of the forecast period, the US market for liquid biopsy tests will exhibit rapid growth through 2029, driven by the aging US population, the shift toward value-based health care, the noninvasive nature of liquid biopsy tests, and the low cost of administration of liquid biopsies relative to tissue-based biopsy testing. These factors will fuel strong uptake of newer tests with improved diagnostic accuracy and reduced turnaround time.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for liquid biopsies in the US across a 10-year period.
The COVID-19 pandemic will negatively impact the US liquid biopsy market.
Which test types and segments will be most impacted?
At what pace will the liquid biopsy market recover?
The use of liquid biopsy tests will expand rapidly over the forecast period.
Which liquid biopsy market segments—screening, therapy selection, or monitoring tests—will experience the highest revenue growth through 2029?
What type of liquid biopsy tests—circulating tumor DNA, circulating tumor cell, or exosome tests—will exhibit the highest growth?
Expansion in CMS reimbursement coverage of liquid biopsy testing, changes in section D Medicare reimbursement, and the continued rollout of Medicare value-based programs will drive liquid biopsy testing.
How will these changes implemented by the CMS affect the liquid biopsy market?
Which liquid biopsy segments will be most affected?
Advancements in liquid biopsy technology—particularly the types of substrates chosen to be isolated and analyzed—continue to drive innovation in the market and differentiate new entrants.
Given the unique nature of every type of substrate, what are the advantages and disadvantages of each substrate within each liquid biopsy segment?
How will advancements in liquid biopsy tests affect the competitive positions of new entrants and the cannibalization of existing products?
Given the nascent nature of the liquid biopsy market, the pace of market expansion going forward will be contingent upon regulatory approvals, consistent research and development funding, and the emergence of favorable clinical data.
Table of contents
- Liquid Biopsy - Market Insights - United States
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Factors Impacting the Liquid Biopsy Market, by Product Type, US
- Liquid Biopsy Market Scenario Forecast, US (USD), 2019u20132029
- Liquid Biopsy Market Landscape, US (USD), 2019 and 2028
- Competitive Highlights
- Competitive Factors and Strategies, by Test Type, US
- Companies Mentioned
- Market Developments
- Recent Events in the Liquid Biopsy Market, US
- Key Clinical Trials in the Liquid Biopsy Market, US
- Emerging Products for the Liquid Biopsy Market, US
- Products Covered
- Liquid Biopsy Products Covered, US
- COVID-19 Updates
- Key Report Updates
- COVID-19 Analysis
- Market Impact
- COVID-19 Impact Assessment Summary, Liquid Biopsy Market, US
- Guidance and Recommendations
- Guidance and Recommendations for Product Liquid Biopsy Procedures
- Major Market Forecast Changes and Assumptions
- Liquid Biopsy Market Scenario Forecast, US (USD), 2019u20132029 (Excluding COVID-19 Impact)
- Liquid Biopsy Market Scenario Forecast, US (USD), 2019u20132029 (Including COVID-19 Impact)
- Competitive Impact
- COVID-19 Competitive Factors and Strategies, Liquid Biopsy Market, US
- COVID-19 Impact by Competitor, Liquid Biopsy Market, US
- Market Impact
- Liquid Biopsy Market
- Market Highlights
- Factors Impacting the Liquid Biopsy Market, by Product Type, US
- Liquid Biopsy Market Scenario Forecast, US (USD), 2019u20132029
- Market Definitions
- Market Forecast Data
- Liquid Biopsy Market, Baseline Scenario, by Test Type, US (USD), 2019u20132029
- Liquid Biopsy Market Growth, Baseline Scenario, by Test Type, US, 2020u20132029
- Liquid Biopsy Market, Optimistic Scenario, by Test Type, US (USD), 2019u20132029
- Liquid Biopsy Market Growth, Optimistic Scenario, by Test Type, US, 2020u20132029
- Liquid Biopsy Market, Pessimistic Scenario, by Test Type, US (USD), 2019u20132029
- Liquid Biopsy Market Growth, Pessimistic Scenario, by Test Type, US, 2020u20132029
- Competitive Highlights
- Market Share Rankings
- Liquid Biopsy Revenue Market Share Rankings, by Product Type, 2019 (market share rankings displayed are from the previous iteration of the report)
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Test Type, US
- Market Developments
- Recent Events in the Liquid Biopsy Market, US
- Key Clinical Trials in the Liquid Biopsy Market, US
- Emerging Products for the Liquid Biopsy Market, US
- Market Highlights
- Screening Test Market
- Market Highlights
- Screening Test Market Scenario Forecast, US (USD), 2019u20132029
- Market Definitions
- Market Forecast Data
- Screening Test Market, Baseline Scenario, by Test Type, US (USD), 2019u20132029
- Screening Test Market Growth, Baseline Scenario, by Test Type, US, 2020u20132029
- Screening Test Market, Optimistic Scenario, by Test Type, US (USD), 2019u20132029
- Screening Test Market Growth, Optimistic Scenario, by Test Type, US, 2020u20132029
- Screening Test Market, Pessimistic Scenario, by Test Type, US (USD), 2019u20132029
- Screening Test Market Growth, Pessimistic Scenario, by Test Type, US, 2020u20132029
- Competitive Highlights
- Market Share Rankings
- Screening Test Revenue Market Share Rankings, 2019 (market share rankings displayed are from the previous iteration of the report)
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Test Type, US
- Market Highlights
- Therapy Selection Test Market
- Market Highlights
- Therapy Selection Test Market Scenario Forecast, US (USD), 2019u20132029
- Market Definitions
- Market Forecast Data
- Therapy Selection Test Market, Baseline Scenario, by Test Type, US (USD), 2019u20132029
- Therapy Selection Test Market Growth, Baseline Scenario, by Test Type, US, 2020u20132029
- Therapy Selection Test Market, Optimistic Scenario, by Test Type, US (USD), 2019u20132029
- Therapy Selection Test Market Growth, Optimistic Scenario, by Test Type, US, 2020u20132029
- Therapy Selection Test Market, Pessimistic Scenario, by Test Type, US (USD), 2019u20132029
- Therapy Selection Test Market Growth, Pessimistic Scenario, by Test Type, US, 2020u20132029
- Competitive Highlights
- Market Share Rankings
- Therapy Selection Test Revenue Market Share Rankings, 2019 (market share rankings displayed are from the previous iteration of the report)
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, US
- Market Highlights
- Monitoring Test Market
- Market Highlights
- Monitoring Test Market Scenario Forecast, US (USD), 2019u20132029
- Market Definitions
- Market Forecast Data
- Monitoring Test Market, Baseline Scenario, by Test Type, US (USD), 2019u20132029
- Monitoring Test Market Growth, Baseline Scenario, by Test Type, US, 2020u20132029
- Monitoring Test Market, Optimistic Scenario, by Test Type, US (USD), 2019u20132029
- Monitoring Test Market Growth, Optimistic Scenario, by Test Type, US, 2020u20132029
- Monitoring Test Market, Pessimistic Scenario, by Test Type, US (USD), 2019u20132029
- Monitoring Test Market Growth, Pessimistic Scenario, by Test Type, US, 2020u20132029
- Competitive Highlights
- Market Share Rankings
- Monitoring Test Revenue Market Share Rankings, 2019 (market share rankings displayed are from the previous iteration of the report)
- Competitive Factors and Strategies
- Competitive Factors and Strategies, by Product Type, US
- Market Highlights
- Abbreviations
- Bibliography
Sophia Quraishi is an analyst on the Medtech Insights team at Decision Resources Group and currently serves as the in-house expert in gastroenterology, open surgery, and liquid biopsy markets. Sophia has been instrumental in leveraging medical claims and hospital purchase order data for expanded new areas of investigation within her fields of expertise. Sophia holds a Bachelor’s degree in Psychology with a specialization in Neuroscience from Columbia University in the City of New York.